A prospective study has revealed that greater fasting glucose variability during young adulthood is independently associated with increased risk for coronary artery calcification progression in middle age.
A collaborative care intervention delivered at urban diabetes clinics improves depressive symptoms and cardiometabolic outcomes among people with comorbid diabetes and depression in India, shows the INDEPENDENT trial.
Among people with obesity and type 2 diabetes, substantial weight loss is associated with similar metabolic benefits irrespective of whether it is achieved through gastric bypass surgery or diet, suggests research published in The New England Journal of Medicine.
The risk for lower limb amputation is not significantly increased among people using SGLT2 inhibitors to treat type 2 diabetes, according to findings from two studies.
Among people with type 2 diabetes, those of African American descent have a higher cardiometabolic risk factor burden than Caucasians at the time of starting treatment with a SGLT2 inhibitor and this might affect long-term treatment response, study findings suggest.
Both type 1 and type 2 diabetes are independently associated with an increased risk for death among hospitalized patients with COVID-19, and a number of factors including poor glycemic control and BMI may predict mortality risk, suggest findings from two studies published in The Lancet Diabetes & Endocrinology.
Analysis of pretreatment follicular helper T cell subpopulations could help to identify which patients with newly diagnosed type 1 diabetes are likely to respond to abatacept immunotherapy, suggests research published in Nature Immunology.
Dapagliflozin reduces the risk for cardiovascular events in people with type 2 diabetes, including those with peripheral artery disease, without increasing the risk for adverse limb events, show DECLARE-TIMI 58 data.
A pilot study indicates that a probiotic supplementation containing mostly anaerobic bacteria may have a role in controlling glucose levels in people with type 2 diabetes.
Patients with rheumatoid arthritis have a lower risk for developing type 2 diabetes relative to individuals without the disease and those with hypertension, osteoarthritis, or psoriatic arthritis, US researchers report.
Researchers studying the MESA cohort have proposed BMI cutoffs at which people from ethnic minorities should be screened for type 2 diabetes, all of which are lower than their proposed cutoff for White people.
Children and adolescents with type 1 diabetes become more diligent about bolusing for insulin at mealtimes in the run-up to a clinic appointment, as reflected in objective data from their insulin pumps.
Canadian clinicians have reported the case of a woman on long-term rosuvastatin treatment who developed rhabdomyolysis within days of starting on canagliflozin.
Analysis of flash glucose monitoring users in Scotland reveals that people with low socioeconomic status had an increased risk for deteriorating glycemic control during the COVID-19 lockdown.
The Dexcom G6 continuous glucose monitoring system may be a good option to help young adults with type 1 diabetes control their blood glucose, show the results of the MILLENNIAL trial.
Severe hypoglycemia in people with type 2 diabetes is associated with later mortality from a wide range of causes, including those for which there is no obvious underlying mechanism, say researchers.
A large population-based study supports an increased risk for diabetic ketoacidosis for users of SGLT2 inhibitors compared with DPP-4 inhibitors, although the absolute risk remains low.
Getting too little or too much sleep is associated with higher death rates among adults with type 2 diabetes when compared to individuals without diabetes, according to data from a large prospective cohort study.
Involving older children with type 1 diabetes in the decision-making process about starting continuous glucose monitoring may help to ensure that they persist with the technology, report researchers.
People with type 1 diabetes treated with multiple daily insulin injections struggle to achieve guideline-recommended targets for time in hypoglycemia while simultaneously reaching their glycated hemoglobin goals, researchers report.